Rheumatoid Arthritis
Rheumatoid arthritis (RA) is a chronic autoimmune disease in which the immune system mistakenly attacks the body's own tissues, primarily the synovium (lining of joints). This causes inflammation that can damage cartilage, bone, and other joint structures. RA typically affects joints symmetrically and can also affect other organs.
Prevalence
Rheumatoid arthritis affects approximately 1.3 million Americans and 1% of the global population. Women are 2-3 times more likely to develop RA than men.
Who It Affects
Can occur at any age but most commonly begins between ages 30-60. Risk factors include family history, smoking, obesity, and certain infections. Women, especially those who have never given birth, are at higher risk.
Important: This information is for educational purposes only and does not constitute medical advice. Regenerative therapies are investigational and not FDA-approved to treat this condition.
Common Symptoms
Common Causes & Risk Factors
Traditional Treatment Options
Disease-Modifying Antirheumatic Drugs (DMARDs)
Medications like methotrexate that slow disease progression and prevent joint damage.
Limitations: Requires regular monitoring. Side effects include liver problems and increased infection risk. Not effective for all patients.
Biologic Agents
Targeted drugs (TNF inhibitors, IL-6 inhibitors) that block specific immune pathways.
Limitations: Expensive. Increased infection risk. Some patients don't respond or lose response over time.
Corticosteroids
Powerful anti-inflammatories to quickly reduce inflammation and pain.
Limitations: Long-term use causes serious side effects (bone loss, weight gain, diabetes). Not suitable for chronic use.
Joint Surgery
Synovectomy, joint fusion, or joint replacement for severely damaged joints.
Limitations: Major surgery. Addresses joint damage but doesn't affect underlying disease.
Regenerative Medicine Approach
How Regenerative Therapy May Help
Regenerative medicine for rheumatoid arthritis is being explored for its potential immunomodulatory effects. Researchers are investigating whether certain biologics may help modulate the overactive immune response that drives RA, though this remains an area of active investigation.
Potential Benefits Being Studied:
- Being studied for potential immunomodulatory effects
- May help reduce inflammation in affected joints
- Contains signaling molecules that may influence immune function
- An area of active research for autoimmune conditions
- May be explored as complement to standard treatments
- Does not replace disease-modifying therapy
Biologics Used:
Mesenchymal stem cells with immunomodulatory properties
Exosomes containing anti-inflammatory signaling molecules
Frequently Asked Questions
Can this cure my rheumatoid arthritis?
No. There is currently no cure for RA. Regenerative therapies are being studied for their potential to help modulate symptoms, but they have not been proven effective for RA and should not replace standard disease-modifying treatments.
Should I stop my RA medications?
No. Never stop or change your RA medications without consulting your rheumatologist. Regenerative therapy, if appropriate, would be considered as a complement to, not replacement for, standard RA treatment.
Is regenerative therapy proven for autoimmune diseases?
Research is ongoing, but regenerative therapies are not yet proven or approved for autoimmune diseases like RA. Any treatment should be discussed with your rheumatologist who manages your overall RA care.
Ready to Explore Your Options?
Schedule a free consultation to discuss rheumatoid arthritis and learn if regenerative medicine may be right for you.
Important Disclaimer
Regenerative therapies for rheumatoid arthritis are highly investigational and not FDA-approved. RA requires ongoing management by a rheumatologist. Never discontinue prescribed medications. Results vary significantly.